https://www.twitter.com/CharlesMBrenner/status/1801074509069648233
my hot take is that rapamycin, by inhibiting skeletal muscle mass, will degrade human quality of life >while NR, by lowering inflammation–shown in 7 human clinical studies–will improve human quality of >life
note that old mice don’t die from falls but frail people do
Charles Brenner has a financial itnerest in NR (Nicotinamide Riboside). However, it is worth looking at his criticism of Rapamycin and I found this.
Our results indicate that although neither rapamycin-sensitive mTOR/mTORC1 nor mTORC2 is necessary for contraction-induced muscle protein synthesis, combined inhibition of rapamycin-sensitive mTOR/mTORC1 and mTORC2 synergistically inhibits contraction-induced muscle protein synthesis.
I don’t think any of this surprises anyone. I think it justifies the more infrequent dosing of Rapamycin, but weekly may be OK.
Whichever way it indicates strongly against inhibiting mTORC2.